These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33991427)

  • 1. cGMP and mitochondrial K
    Lukowski R; Cruz Santos M; Kuret A; Ruth P
    Br J Pharmacol; 2022 Jun; 179(11):2344-2360. PubMed ID: 33991427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
    Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
    Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.
    Burley DS; Ferdinandy P; Baxter GF
    Br J Pharmacol; 2007 Nov; 152(6):855-69. PubMed ID: 17700722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM; Range S; Holland E; Knox AJ
    Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium nitroprusside protects adult rat cardiac myocytes from cellular injury induced by simulated ischemia: role for a non-cGMP-dependent mechanism of nitric oxide protection.
    Garreffa AM; Woodman OL; Cao AH; Ritchie RH
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):1-8. PubMed ID: 16424779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cGMP signalling in auditory processing in health and disease.
    Marchetta P; Rüttiger L; Hobbs AJ; Singer W; Knipper M
    Br J Pharmacol; 2022 Jun; 179(11):2378-2393. PubMed ID: 33768519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO-sensitive guanylyl cyclase in the lung.
    Friebe A; Englert N
    Br J Pharmacol; 2022 Jun; 179(11):2328-2343. PubMed ID: 33332689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection.
    Oldenburg O; Qin Q; Krieg T; Yang XM; Philipp S; Critz SD; Cohen MV; Downey JM
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H468-76. PubMed ID: 12958031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualising and understanding cGMP signals in the cardiovascular system.
    Feil R; Lehners M; Stehle D; Feil S
    Br J Pharmacol; 2022 Jun; 179(11):2394-2412. PubMed ID: 33880767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism.
    Qin Q; Yang XM; Cui L; Critz SD; Cohen MV; Browner NC; Lincoln TM; Downey JM
    Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H712-8. PubMed ID: 15044194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
    Geng Y; Zhou L; Thompson WJ; Lotz M
    J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS.
    Pasdois P; Quinlan CL; Rissa A; Tariosse L; Vinassa B; Costa AD; Pierre SV; Dos Santos P; Garlid KD
    Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1470-8. PubMed ID: 17098831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance proteins preferentially regulate natriuretic peptide-driven cGMP signalling in the heart and vasculature.
    Grange RMH; Preedy MEJ; Renukanthan A; Dignam JP; Lowe VJ; Moyes AJ; Pérez-Ternero C; Aubdool AA; Baliga RS; Hobbs AJ
    Br J Pharmacol; 2022 Jun; 179(11):2443-2459. PubMed ID: 34131904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
    Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
    Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening.
    D'Souza SP; Yellon DM; Martin C; Schulz R; Heusch G; Onody A; Ferdinandy P; Baxter GF
    Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1592-600. PubMed ID: 12521930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion.
    Tourki B; Matéo P; Morand J; Elayeb M; Godin-Ribuot D; Marrakchi N; Belaidi E; Messadi E
    PLoS One; 2016; 11(9):e0162632. PubMed ID: 27618302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.